Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/39826
Title: A randomised controlled trial of paracetamol and ibuprofen with or without codeine or oxycodone as initial analgesia for adults with moderate pain from limb injury.
Authors: Egerton-Warburton D. ;Meyer A. ;Parkinson J.;Meek R. ;Graudins A. 
Institution: (Graudins) Monash Health Emergency Medicine Research Unit, Dandenong Hospital, Melbourne, VIC, Australia (Graudins, Meek) Monash Emergency, Dandenong Hospital, Melbourne, VIC, Australia (Egerton-Warburton) Monash Emergency, Monash Medical Center, Melbourne, VIC, Australia (Meyer) Monash Emergency, Casey Hospital, Melbourne, VIC, Australia (Parkinson) Pharmacy Department, Monash Medical Center, Melbourne, VIC, Australia (Graudins, Meek, Parkinson, Egerton-Warburton, Meyer) School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
Issue Date: 17-Dec-2016
Copyright year: 2016
Publisher: Blackwell Publishing (E-mail: info@asia.blackpublishing.com.au)
Place of publication: Australia
Publication information: EMA - Emergency Medicine Australasia. 28 (6) (pp 666-672), 2016. Date of Publication: 01 Dec 2016.
Journal: EMA - Emergency Medicine Australasia
Abstract: Objective: Compare pain relief from non-opioid, codeine and oxycodone analgesic regimens in adults with moderate pain from limb injury. Method(s): Double-blind, randomised, controlled, non-inferiority trial. Three regimens of six tablets, each included 2 x 500 mg paracetamol and 2 x 200 mg ibuprofen with 2 x 100 mg thiamine (non-opioid), 2 x 30 mg codeine (codeine) or 2 x 5 mg oxycodone tablets (oxycodone). Primary Outcome: difference in mean visual analogue scale (VAS) change between groups at 30 min, with a limit of inferiority of 13. Secondary outcomes included mean change in VAS rating from baseline to 30 min for each group, patient satisfaction, need for additional analgesia and adverse events. Pain ratings taken at 60 and 90 min for patients still in ED are described. Result(s): Of 182 patients randomised, non-opioid, codeine and oxycodone numbers were 61, 62 and 59. Differences (95% CI) between groups at 30 min were as follows: non-opioid versus codeine -2.6 (-8.8 to 3.6); non-opioid versus oxycodone -2.7 (-9.3 to 3.9); codeine versus oxycodone 0.1 (-6.6 to 6.4). Mean VAS reductions for non-opioid, codeine and oxycodone were -13.5, -16.1 and -16.2 mm, respectively. Satisfaction with analgesia was reported by 77.6% (64.7-87.5), 81.0% (67.2-89.0) and 73.6% (59.7-84.7) and adverse events by 3.3% (0.4-11.3), 1.6% (0.4-8.7) and 16.9% (8.4-29.0), respectively. Mean VAS reductions at 60 and 90 min were as follows: -23.2 and -18.7 mm for non-opioid; -30.7 and -33.3 mm for codeine; and -26.1 and -31.7 mm for oxycodone. Conclusion(s): At 30 min, analgesic effects of non-opioid, codeine and oxycodone groups were non-inferior.Copyright © 2016 Australasian College for Emergency Medicine and Australasian Society for Emergency Medicine
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/1742-6723.12672
PubMed URL: 27599896 [http://www.ncbi.nlm.nih.gov/pubmed/?term=27599896]
ISSN: 1742-6731
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/39826
Type: Article
Type of Clinical Study or Trial: Randomised controlled trial
Appears in Collections:Articles

Show full item record

Page view(s)

24
checked on Sep 12, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.